Allogeneic Transplantation for Advanced AML: The Value of Complete Remission

BACKGROUND: Patients with AML without complete remission (CR) or in first relapse (relapse1) can have extended leukemia control and survival following allogeneic hematopoietic cell transplantation (HCT). Transplantation in relapse1 or primary induction failure (PIF) versus treatment to achieve CR2 a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer
Main Authors: Weisdorf, Daniel, Millard, Heather R., Horowitz, Mary M., Hyare, Parvinder S., Champlin, Richard, Ho, Vincent, Mielcarek, Marco, Rezvani, Andrew, Stockerl-Goldstein, Keith, Khoury, Hanna J., De Lima, Marcos, Saber, Wael, Sandmaier, Brenda, Zhang, Mei Jie, Eapen, Mary
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5445001/
https://ncbi.nlm.nih.gov/pubmed/28117884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30536
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares